indomethacin has been researched along with Neurally Mediated Faint in 1 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lewis, NC | 1 |
Bain, AR | 1 |
MacLeod, DB | 1 |
Wildfong, KW | 1 |
Smith, KJ | 1 |
Willie, CK | 1 |
Sanders, ML | 1 |
Numan, T | 1 |
Morrison, SA | 1 |
Foster, GE | 1 |
Stewart, JM | 1 |
Ainslie, PN | 1 |
1 trial available for indomethacin and Neurally Mediated Faint
Article | Year |
---|---|
Impact of hypocapnia and cerebral perfusion on orthostatic tolerance.
Topics: Adult; Cerebrovascular Circulation; Cyclooxygenase Inhibitors; Female; Homeostasis; Humans; Hyperven | 2014 |